Jianan Jin

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Respiratory adverse events associated with PD-1/PD-L1 inhibitors: an analysis based on the FDA adverse event reporting system.

Respiratory adverse events associated with PD-1/PD-L1 inhibitors: an analysis based on the FDA adverse event reporting system.

Journal: Frontiers in oncology

Published: January 15, 2026

Molecular Typing and Drug Resistance of Methicillin-Resistant Staphylococcus aureus in Skin and Soft Tissue Infections in Shaoxing.

Molecular Typing and Drug Resistance of Methicillin-Resistant Staphylococcus aureus in Skin and Soft Tissue Infections in Shaoxing.

Journal: The new microbiologica

Published: October 22, 2025

Social determinants of health and Helicobacter pylori infection prevalence: a systematic review and meta-analysis.

Social determinants of health and Helicobacter pylori infection prevalence: a systematic review and meta-analysis.

Journal: Frontiers in public health

Published: September 11, 2025

Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRASG12D Inhibitor.

Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRASG12D Inhibitor.

Journal: Cancer discovery

Published: August 02, 2025

Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database.

Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database.

Journal: PloS one

Published: April 24, 2025

Nomogram for Predicting Survival Post-Immune Therapy in Cholangiocarcinoma Based on Inflammatory Biomarkers.

Nomogram for Predicting Survival Post-Immune Therapy in Cholangiocarcinoma Based on Inflammatory Biomarkers.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: December 05, 2024

The relationship between epigenetic biomarkers and the risk of diabetes and cancer: a machine learning modeling approach.

The relationship between epigenetic biomarkers and the risk of diabetes and cancer: a machine learning modeling approach.

Journal: Frontiers in public health

Published: October 11, 2024

Comparison of efficacy and safety of second- and third-generation TKIs for non-small-cell lung cancer with uncommon EGFR mutations.

Comparison of efficacy and safety of second- and third-generation TKIs for non-small-cell lung cancer with uncommon EGFR mutations.

Journal: Cancer medicine

Published: January 22, 2023

Host-Guest Encapsulation to Promote the Formation of a Multicomponent Trigonal-Prismatic Metallacage.

Host-Guest Encapsulation to Promote the Formation of a Multicomponent Trigonal-Prismatic Metallacage.

Journal: Inorganic chemistry

Published: December 05, 2022

Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma.

Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: August 24, 2022

The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study.

The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study.

Journal: Cancer medicine

Published: August 01, 2022

Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.

Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.

Journal: Journal of thoracic disease

Published: November 19, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026